NanJing Pharmaceutical Co Ltd (600713) — Financial Flexibility Index
NanJing Pharmaceutical Co Ltd (600713) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of CN¥-906.23 Million (operating CF CN¥-942.93 Million minus capex CN¥36.70 Million) represents 0% of total liabilities (CN¥26.09 Billion). Check NanJing Pharmaceutical Co Ltd (600713) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NanJing Pharmaceutical Co Ltd Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for NanJing Pharmaceutical Co Ltd across 27 annual periods. See 600713 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for NanJing Pharmaceutical Co Ltd (1998–2024)
Year-by-year free cash flow to debt coverage for NanJing Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600713 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | CN¥2.68 Billion | CN¥2.14 Billion | CN¥22.89 Billion | ▲ +20.0% |
| 2023 | 0.10x | CN¥2.06 Billion | CN¥1.91 Billion | CN¥21.16 Billion | ▲ +562.1% |
| 2022 | -0.02x | CN¥-527.03 Million | CN¥-682.31 Million | CN¥24.96 Billion | ▼ -143.5% |
| 2021 | 0.05x | CN¥1.00 Billion | CN¥695.33 Million | CN¥20.65 Billion | ▲ +199.6% |
| 2020 | -0.05x | CN¥-905.49 Million | CN¥-1.15 Billion | CN¥18.59 Billion | ▼ -165.1% |
| 2019 | 0.07x | CN¥1.30 Billion | CN¥1.00 Billion | CN¥17.45 Billion | ▲ +2185.7% |
| 2018 | 0.00x | CN¥-55.38 Million | CN¥-366.90 Million | CN¥15.45 Billion | ▼ -108.1% |
| 2017 | 0.04x | CN¥560.56 Million | CN¥319.99 Million | CN¥12.74 Billion | ▲ +1164.3% |
| 2016 | 0.00x | CN¥-45.03 Million | CN¥-240.88 Million | CN¥10.89 Billion | ▲ +70.7% |
| 2015 | -0.01x | CN¥-139.73 Million | CN¥-306.08 Million | CN¥9.91 Billion | ▲ +33.6% |
| 2014 | -0.02x | CN¥-189.67 Million | CN¥-341.01 Million | CN¥8.92 Billion | ▲ +7.6% |
| 2013 | -0.02x | CN¥-192.26 Million | CN¥-354.27 Million | CN¥8.36 Billion | ▼ -141.5% |
| 2012 | 0.06x | CN¥438.89 Million | CN¥168.17 Million | CN¥7.91 Billion | ▲ +267.3% |
| 2011 | -0.03x | CN¥-254.15 Million | CN¥-692.53 Million | CN¥7.67 Billion | ▼ -159.9% |
| 2010 | 0.06x | CN¥393.58 Million | CN¥119.08 Million | CN¥7.11 Billion | ▲ +91.1% |
| 2009 | 0.03x | CN¥167.19 Million | CN¥20.22 Million | CN¥5.77 Billion | ▲ +5.7% |
| 2008 | 0.03x | CN¥121.44 Million | CN¥4.33 Million | CN¥4.43 Billion | ▼ -28.9% |
| 2007 | 0.04x | CN¥165.50 Million | CN¥81.08 Million | CN¥4.30 Billion | ▼ -41.9% |
| 2006 | 0.07x | CN¥201.70 Million | CN¥161.31 Million | CN¥3.04 Billion | ▼ -17.5% |
| 2005 | 0.08x | CN¥215.37 Million | CN¥165.57 Million | CN¥2.68 Billion | ▲ +73.0% |
| 2004 | 0.05x | CN¥116.98 Million | CN¥16.26 Million | CN¥2.52 Billion | ▲ +0.6% |
| 2003 | 0.05x | CN¥93.17 Million | CN¥19.27 Million | CN¥2.02 Billion | ▼ -77.2% |
| 2002 | 0.20x | CN¥266.02 Million | CN¥68.75 Million | CN¥1.31 Billion | ▲ +244.0% |
| 2001 | 0.06x | CN¥41.17 Million | CN¥-4.20 Million | CN¥697.93 Million | ▼ -61.9% |
| 2000 | 0.16x | CN¥115.07 Million | CN¥87.68 Million | CN¥742.31 Million | ▲ +0.1% |
| 1999 | 0.15x | CN¥77.64 Million | CN¥50.58 Million | CN¥501.56 Million | ▼ -55.7% |
| 1998 | 0.35x | CN¥153.84 Million | CN¥77.45 Million | CN¥440.31 Million | — |